Skip to main content
. 2022 Nov 8;150:e204. doi: 10.1017/S0950268822001182

Table 4.

Fatality rates for hospitalised cases of ACP and IPD in the overall study population and in each stratification

ACP IPD
N = 15 983 N = 164
Overall number of deaths Rate per 100 cases 95% CI Rate per 100 cases 95% CI
Overall 17.22 16.98–17.47 16.89 14.66–19.38
Year
2016 16.92 16.45–17.39 15.60 11.63–20.61
2017 17.30 16.83–17.78 16.59 12.28–22.03
2018 17.82 17.33–18.31 18.73 14.61–23.68
2019 16.75 16.25–17.26 16.13 11.83–21.60
Trend test (P value)a 1.00 0.75
Age at study entry
16–49 4.42 3.98–4.91 8.74 4.67–15.78
50–59 10.95 10.32–11.62 13.16 9.07–18.70
60–69 14.10 13.54–14.68 12.50 8.73–17.58
≥70 20.36 20.04–20.67 22.29 18.74–26.31
Sex
Male 17.64 17.31–17.97 18.10 15.07–21.58
Female 16.70 16.34–17.06 15.40 12.31–19.10
Presence of medical condition in the pre-period
At-risk 15.32 14.96–15.69 14.52 11.30–18.46
High-risk 19.60 19.25–19.95 18.84 15.60–22.57
None 10.17 9.47–10.92 16.38 10.74–24.17

ACP, all-cause pneumonia; CI, confidence interval; IPD, invasive pneumococcal disease.

a

Mann–Kendall test for trend.